Dear Colleagues,
It is with great anticipation and excitement that I extend on behalf of the organizing committee a cordial invitation to all of you to join the 9th International Congress of Internal Medicine which will be held this year on March 9-11, 2017 in Athens, Greece.
In this website you will find all the information needed concerning the implementation of the congress. The material will soon be enriched with further details for your convenience.
This is a major annual event in Greece attended nationally and internationally by upwards of 600-700 attendees from all over the country and European countries and with the active participation of established international scientists and experts.
The last years the organizing and scientific committee has been focusing on a single goal: hopefully to make this congress an important scientific event beyond the Greek borders, open to friendships and collaborations, that will gain worldwide warm acceptance and recognition for its scientific merit. The success of the past congresses shows us that we walk on the right path towards this goal, enhances our passion and willingness for continuing this educational undertaking.
At this point more than 70 established international scientists and experts of great impact have already confirmed their participation as faculty members. The scientific program will also include the traditional form of the abstract based sessions and will provide young-and not only-colleagues with a great opportunity to present their work, research and clinical experience through oral presentations and e-posters covering various section fields of Internal Medicine. Therefore we encourage interested colleagues to actively participate in the programme and submit abstracts of their work through the website of the Congress.
We are confident that the Congress will represent for all participants an unforgettable personal and professional experience, and we look forward to welcoming you in Athens.
Best regards,
The President of the Organizing Committee
George N. Dalekos
Professor of Medicine,
President, Institute of Internal Medicine and Hepatology,
President, Hellenic Association for the Study of the Liver,
Vice President, Internal Medicine Society of Northern Greece,
Head, Department of Medicine and Research Laboratory of Internal Medicine,
Medical School, University of Thessaly, Larissa, Greece
Organizers
INSTITUTE OF INTERNAL MEDICINE & HEPATOLOGY, LARISSA, GREECE
DEPARTMENT OF MEDICINE & RESEARCH LABORATORY OF INTERNAL MEDICINE,
UNIVERSITY OF THESSALY MEDICAL SCHOOL, LARISSA, GREECE
Director: Professor G.N. Dalekos
In cooperation with:
HELLENIC ASSOCIATION FOR THE STUDY OF THE LIVER
HELLENIC STROKE ORGANIZATION
BOARD OF THE HELLENIC ASSOCIATION FOR THE STUDY OF THE LIVER
| President: | G.N. Dalekos |
| Vice President: | G. Papatheodoridis |
| Gen. Secretary: | E. Cholongitas |
| Treasurer: | A. Alexopoulou |
| Member: | C. Triantos |
Endorsed by:
EUROPEAN FEDERATION OF INTERNAL MEDICINE
FOUNDATION FOR THE DEVELOPMENT OF INTERNAL MEDICINE IN EUROPE
Under the auspices of:
MINISTRY OF HEALTH, GREECE
UNIVERSITY OF THESSALY MEDICAL SCHOOL, LARISSA, GREECE
SPEAKERS confirmed
COUNTRIES
DAYS
Preliminary Scientific Program
ORAL PRESENTATIONS
STATE -OF THE ART- LECTURE
Importance of European registries on rare liver diseases: The paradigm of autoimmune hepatitis
Rodrigo Liberal (London, UK)
ROUND TABLE - Hypolipidemic treatment: What is new?
Should we treat everyone above 60 years with a statin?
Chris J Packard (Glasgow, UK)
Familial hypercholesterolemia diagnosis and treatment: Can we perform better?
G. Kees Hovingh (Amsterdam, The Netherlands)
PCSK9 inhibition: What is hot in 2017?
Terje Rolf Pedersen (Oslo, Norway)
SYMPOSIUM - Intensive blood pressure control
Pros
Michel Burnier (Lausanne, Switzerland)
Cons
Alberto Zanchetti (Milan, Italy)
ROUND TABLE - Stroke etiology and management
Hellenic Stroke Organization
Stroke in the young
Jukka Putaala (Helsinki, Finland)
Drug-induced stroke
Jose Ferro (Lisbon, Portugal)
Can we predict thrombolysis-associated symptomatic intracranial hemorrhage?
Daniel Strbian (Helsinki, Finland)
Management of intracranial artery stenosis
Christian Weimar (Essen, Germany)
ROUND TABLE - Heart and stroke
Hellenic Stroke Organization
Patent foramen ovale in cryptogenic stroke: Closure, antiplatelets or anticoagulants?
Heinrich Mattle (Bern, Switzerland)
Optimal strategy for detection of atrial fibrillation in patients with cryptogenic stroke
Martin Kohrmann (Erlangen, Germany)
Acute treatment in patients with acute ischemic stroke treated with oral anticoagulants
George Ntaios (Larissa, Greece)
OPENING CEREMONY
Welcome
Inaugural Lecture
Improving health care by innovations and clinical research
Daniel Sereni (Paris, France)
President of the Federation for the Development of Internal Medicine in Europe (FDIME)
ORAL PRESENTATIONS
ROUND TABLE - Obesity: From epidemiology to treatment
Epidemiology, definition and diagnosis of obesities
Hermann Toplak (Graz, Austria)
Obesity, impaired glucose metabolism and vascular changes
Peter Nilsson (Malmo, Sweden)
Mechanisms of obesity induced hypertension
Vasilios Kotsis (Thessaloniki, Greece)
Novel drugs in the treatment of obesity
Jens Jordan (Hannover, Germany)
ROUND TABLE - Advances in viral hepatitis management (PARALLEL SESSION)
Hellenic Association for the Study of the Liver
Chronic hepatitis B: Discontinuation of oral antivirals
Stephanos J. Hadziyannis (Athens, Greece)
Chronic hepatitis C: Challenges in special populations
Heiner Wedemeyer (Hannover, Germany)
Chronic hepatitis delta: An update
Cihan Yurdaydin (Ankara, Turkey)
ROUND TABLE - New developments in diabetes mellitus
Hellenic Diabetes Association
Novel approaches to manage dyslipidaemia, NAFLD and CV risk in type 2 diabetes
Manfredi Rizzo (Palermo, Italy)
Silent myocardial ischaemia in diabetes: new developments
Paul Valensi (Paris, France)
Diabetic neuropathy: new developments in early diagnosis and treatment
Dan Ziegler (Düsseldorf, Germany)
ROUND TABLE - Treatment innovations in rheumatic diseases (PARALLEL SESSION)
Treatment of ANCA-associated vasculitis: Questions and concerns
Loic Guillevin (Paris, France)
Biological-targeted treatments in giant cell arteritis and eosinophilic granulomatosis with polyangitis (Churg-Strauss)
Maxime Samson (Dijon, France)
Primary Sjögren’s syndrome: How to improve specific treatment?
Yves Renaudineau (Brest, France)
Axial spondyloarthritis and psoriatic arthritis: Emerging treatment strategies
Menelaos N. Manoussakis (Athens, Greece)
SYMPOSIUM - Staphylococcal infections
Choosing antibiotics in difficult to treat staphylococcal infections
Francesco Menichetti (Pisa, Italy)
Optimizing treatment strategies in S. aureus bacteremia
Serhat Unal (Ankara, Turkey)
STATE -OF THE ART- LECTURE
Hellenic Stroke Organization
Transient ischemic attack and minor strokes: definition, diagnosis, imaging and natural history
Pierre Amarenco (Paris,France)
ROUND TABLE - Internal Medicine in the 21st century
European Federation of Internal Medicine (EFIM)
European Curriculum of Internal Medicine
Runólfur Pálsson (Reykjavik, Iceland)
Choosing wisely: To be or not to be – that’s the question
Nicola Montano (Milan,Italy)
The role of EFIM publications for trainees and specialists
Pier Mannucio Mannucci (Milan,Italy)
STATE -OF THE ART- LECTURE
Selecting the appropriate antithrombotic strategy in atrial fibrillation
Gregory Lip (Birmingham, UK)
ORAL PRESENTATIONS
ROUND TABLE - Global health security: Threats and opportunities
Global health and population movements
Varvara Mouchtouri (Larissa, Greece)
The role of points of entry (ports, airports, ground, crossings) in global health security
Daniel Lins Menucci, WHO Headquarters (Lyon, France)
The impact of the International Health Regulations 2005 in global health security
Thomas Hoffman, WHO Euro (Copenhagen, Denmark))
The role of European Union in the global health security
TBA
SYMPOSIUM - Acute kidney injury after abdominal surgery (PARALLEL SESSION)
TBA
TBA
TBA
TBA
STATE -OF THE ART- LECTURE
Autoimmune serology: The strategy, methodology and clinical governance
Diego Vergani (London, UK)
ROUND TABLE - Autoimmune cholestatic liver diseases
Scientific and practical aspects of registries in primary biliary cholangitis (PBC)
Henk R. van Buuren (Rotterdam, The Netherlands)
PBC: Old and novel therapies
Annarosa Floreani (Padova, Italy)
Variant syndromes: Classification and management
Albert Pares (Barcelona, Spain)
Deranged cholestatic enzymes in a patient with inflammatory bowel disease: What to do?
Gideon Hirschfield (Birmingham, UK)
STATE -OF THE ART- LECTURE
Disease specific IVIG to treat diverse autoimmune diseases
Miri Blank (Tel Aviv, Israel)
ROUND TABLE - Highlights in intensive care unit (ICU) infections
Prevention of ventilator-associated pneumonia (VAP): could be realistic?
Stijn Blot (Ghent, Belgium)
Reducing the antifungal drugs consumption in the ICU
Philippe Montravers (Paris, France)
Fighting multi-drug resistant (MDR) pathogens in the ICU
Murat Akova (Ankara, Turkey)
ROUND TABLE - NAFLD - NASH: From pathogenesis to treatment (PARALLEL SESSION)
Steatosis and metabolic risk factors: Who is at risk of liver disease progression
Mattias Ekstedt (Linköping, Sweden)
NAFLD genetics
Quentin Anstee (Newcastle, UK)
Non-invasive assessment of liver fibrosis in NAFLD
Emmanuel Tsochatzis (London, UK)
Novel pharmacotherapy options for NASH
Vlad Ratziu (Paris, France)
STATE -OF THE ART- LECTURE
The coagulopathy of chronic liver disease
Pier Mannucio Mannucci (Milan, Italy)
SYMPOSIUM - Lymphocyte disruptions in autoimmune diseases
Diagnostic accuracy of lymphocyte subset profiling in autoimmune diseases
Christoph Jamin (Brest, France)
Myeloid populations are altered in systemic autoimmune diseases
Concepción Marañón (Granada, Spain)
SYMPOSIUM - Practical guidelines for diagnosis, management and outcome of drug-induced liver injury (DILI) (PARALLEL SESSION)
Diagnostic evaluation of suspected DILI
Ynto de Boer (Amsterdam, The Netherlands)
Management and outcome of DILI in patients with or without chronic liver disease
Alexandra Alexopoulou (Athens, Greece)
Sponsors-Expression of interest
A major exhibition will accompany the Congress, where pharmaceutical and/or equipment/device industries will display relevant products, services and therapeutic developments, reach and interact with the medical community, promote their activities, research and technologies.
For relative information interested Companies may contact the Organizing-Administrative Bureau
Εmail: info@conferre.gr
Tel.: (+30) 26510 68610
Fax: (+30) 26510 68611
Contact person: Mrs Lina Siamopoulou
Location
Hilton Athens Hotel, Greece
- 46 Vasilissis Sofias Avenue,11528
- reservations.athens@hilton.com
- +30-210-7281000
- +30-210-7281111